ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL
Serial Number: 85525635
Word Mark: ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL
Goods and Services: (ABANDONED) IC 042. US 100 101. G & S: Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use for pharmaceutical research and development
Mark Drawing Code: (4) STANDARD CHARACTER MARK
Filing Date: 01/26/2012
Current Basis: 1B
Original Filing Basis: 1B
Disclaimer: NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO USE "IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL" APART FROM THE MARK AS SHOWN
Type of Mark: SERVICE MARK
Register: PRINCIPAL
Live/Dead Indicator: DEAD
SiteNo: 6394